ArticleFrontiers in aging neuroscience2022

Heterogeneous nuclear ribonucleoprotein A2/B1 as a novel biomarker in elderly patients for the prediction of postoperative neurocognitive dysfunction: A prospective nested case-control study.

Tong Xia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.